DE69020199T2 - Durch Azetidine substituierte Derivate von Pyridon-Carboxylsäure, ihre Herstellung und Verwendung als Arzneimittel. - Google Patents

Durch Azetidine substituierte Derivate von Pyridon-Carboxylsäure, ihre Herstellung und Verwendung als Arzneimittel.

Info

Publication number
DE69020199T2
DE69020199T2 DE69020199T DE69020199T DE69020199T2 DE 69020199 T2 DE69020199 T2 DE 69020199T2 DE 69020199 T DE69020199 T DE 69020199T DE 69020199 T DE69020199 T DE 69020199T DE 69020199 T2 DE69020199 T2 DE 69020199T2
Authority
DE
Germany
Prior art keywords
derivatives
azetidines
medicines
preparation
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69020199T
Other languages
English (en)
Other versions
DE69020199D1 (de
Inventor
Corominas Juan Pares
Pinol Augusto Colombo
Constansa Jordi Frigola
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8903459A external-priority patent/FR2644455B1/fr
Priority claimed from FR8908695A external-priority patent/FR2649106A2/fr
Priority claimed from FR8915178A external-priority patent/FR2654728B2/fr
Application filed by Individual filed Critical Individual
Publication of DE69020199D1 publication Critical patent/DE69020199D1/de
Application granted granted Critical
Publication of DE69020199T2 publication Critical patent/DE69020199T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
DE69020199T 1989-03-16 1990-03-14 Durch Azetidine substituierte Derivate von Pyridon-Carboxylsäure, ihre Herstellung und Verwendung als Arzneimittel. Expired - Fee Related DE69020199T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR8903459A FR2644455B1 (fr) 1989-03-16 1989-03-16 Derives d'acides pyridone carboxyliques azetidinyl substitues, leur preparation et leur application en tant que medicaments
FR8908695A FR2649106A2 (fr) 1989-06-29 1989-06-29 Derives d'acides pyridone carboxyliques azetidinyl substitues, leur preparation et leur application en tant que medicament
FR8915178A FR2654728B2 (fr) 1989-03-16 1989-11-20 Derives d'acides pyridone carboxyliques azetidinyl substitues, leur preparation et leur application en tant que medicament.

Publications (2)

Publication Number Publication Date
DE69020199D1 DE69020199D1 (de) 1995-07-27
DE69020199T2 true DE69020199T2 (de) 1995-12-14

Family

ID=27251837

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69020199T Expired - Fee Related DE69020199T2 (de) 1989-03-16 1990-03-14 Durch Azetidine substituierte Derivate von Pyridon-Carboxylsäure, ihre Herstellung und Verwendung als Arzneimittel.

Country Status (16)

Country Link
US (1) US5393758A (de)
EP (1) EP0388298B1 (de)
JP (1) JPH075586B2 (de)
KR (1) KR940006595B1 (de)
AT (1) ATE124039T1 (de)
AU (2) AU638437B2 (de)
CA (1) CA2012223A1 (de)
DE (1) DE69020199T2 (de)
DK (1) DK0388298T3 (de)
ES (1) ES2022006A6 (de)
GR (1) GR3017304T3 (de)
HU (1) HU206702B (de)
NO (1) NO177302C (de)
PT (1) PT93450B (de)
RU (1) RU2044735C1 (de)
YU (1) YU47430B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100196440B1 (ko) * 1990-12-05 1999-06-15 로널드 지,미세티취 항균제로서 유용한 7-치환-6-플루오로-1, 4-디하이드로-4-옥소-퀴놀린-3-카르복실산화합물
US5342846A (en) * 1990-12-05 1994-08-30 Synphar Laboratories, Inc. 7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid compounds and 7-(substituted triazolyl pyrrolidin-1-yl) 4-oxoquinoline-3-carboxylic acid derivatives useful as antibacterial agents
FR2676445B1 (fr) * 1991-05-16 1995-02-03 Esteve Labor Dr Derives de pyridone amino acide azetidinyl substitues, leur preparation et leur application en tant que medicaments.
FR2681865B1 (fr) * 1991-10-01 1993-11-19 Bel Laboratoire Roger Nouveaux derives de la benzonaphtyridine-1,8 leur preparation et les compositions qui les contiennent.
US5221676A (en) * 1992-02-06 1993-06-22 Warner-Lambert Company 7-substituted quinolones and naphthyridones as antibacterial agents
FR2690161B1 (fr) * 1992-04-16 1995-06-30 Esteve Labor Dr Derives de pyridone azetidinyl substitues avec activite antimicrobienne.
JPH0999195A (ja) * 1995-10-02 1997-04-15 Eiji Maruko 高能率電子洗濯法
NZ516201A (en) * 1999-07-01 2003-06-30 Wakunaga Pharamaceutical Co Quinolinecarboxylic acid derivative or salts thereof that have antimicrobial effect
WO2005026146A1 (en) * 2003-09-12 2005-03-24 Warner-Lambert Company Llc Azetidinyl quinolones as antibacterial agents

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998808A (en) * 1968-05-22 1976-12-21 Velsicol Chemical Corporation Compositions of matter D-hetero-1,1-(α-thiocyanoacetyl) compounds
US4183923A (en) * 1977-11-07 1980-01-15 Schering Corporation Antipsoriatic compositions
JPS5746986A (en) * 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
IE55898B1 (en) * 1982-09-09 1991-02-14 Warner Lambert Co Antibacterial agents
US4665079A (en) * 1984-02-17 1987-05-12 Warner-Lambert Company Antibacterial agents
US4777175A (en) * 1982-09-09 1988-10-11 Warner-Lambert Company Antibacterial agents
JPS6089480A (ja) * 1983-10-21 1985-05-20 Dainippon Pharmaceut Co Ltd ピリドンカルボン酸誘導体
JPS60126284A (ja) * 1983-12-09 1985-07-05 Dainippon Pharmaceut Co Ltd ピリドンカルボン酸誘導体およびその塩
FR2560194B1 (fr) * 1984-02-27 1987-08-07 Midy Spa 3-aminoazetidine, ses sels, procede pour leur preparation et intermediaires de synthese
JPS61137885A (ja) * 1984-12-08 1986-06-25 Dainippon Pharmaceut Co Ltd 1,8−ナフチリジン誘導体、そのエステルおよびその塩
JPS61143383A (ja) * 1985-10-28 1986-07-01 Toyama Chem Co Ltd 1,4−ジヒドロ−4−オキソナフチリジン誘導体またはその塩を含有する抗菌剤
JPS63198664A (ja) * 1986-03-31 1988-08-17 Sankyo Co Ltd キノロンカルボン酸誘導体
EP0241206A3 (de) * 1986-03-31 1989-05-10 Sankyo Company Limited Chinolin-3-carbonsäurederivate, ihre Herstellung und Verwendung
JPH0633262B2 (ja) * 1987-10-12 1994-05-02 富山化学工業株式会社 1,4−ジヒドロ−4−オキソナフチリジン誘導体およびその塩
US5039683A (en) * 1987-10-26 1991-08-13 Pfizer Inc. Azetidinyl quinolone carboxylic acids and esters
FR2634483B2 (fr) * 1987-12-29 1994-03-04 Esteve Labor Dr Derives des acides 7-(1-azetidinyl)-1,4-dihydro-4-oxoquinoleine-3-carboxyliques, leur preparation et leur application en tant que medicaments

Also Published As

Publication number Publication date
AU638437B2 (en) 1993-07-01
AU4746993A (en) 1993-12-02
RU2044735C1 (ru) 1995-09-27
YU50590A (sh) 1993-05-28
NO177302B (no) 1995-05-15
JPH075586B2 (ja) 1995-01-25
ES2022006A6 (es) 1991-11-16
KR900014380A (ko) 1990-10-23
HU901570D0 (en) 1990-06-28
DK0388298T3 (da) 1995-08-14
DE69020199D1 (de) 1995-07-27
PT93450A (pt) 1990-11-07
US5393758A (en) 1995-02-28
ATE124039T1 (de) 1995-07-15
CA2012223A1 (en) 1990-09-16
AU5137590A (en) 1990-09-20
NO177302C (no) 1995-08-23
PT93450B (pt) 1996-07-31
HUT53643A (en) 1990-11-28
YU47430B (sh) 1995-03-27
JPH02279683A (ja) 1990-11-15
EP0388298A3 (de) 1991-07-31
KR940006595B1 (ko) 1994-07-23
GR3017304T3 (en) 1995-12-31
AU648212B2 (en) 1994-04-14
EP0388298B1 (de) 1995-06-21
HU206702B (en) 1992-12-28
NO901171D0 (no) 1990-03-13
EP0388298A2 (de) 1990-09-19
NO901171L (no) 1990-09-17

Similar Documents

Publication Publication Date Title
DK543787A (da) Naphthyridin-, quinolin- og benzoxazincarboxylsyreforbindelser med antibakteriel aktivitet
ATE150749T1 (de) Substituierte heterocyclische carbonsäureamide, ihre herstellung und ihre verwendung als arzneimittel
ATE88344T1 (de) Zur behandlung von neurodegenerativen erkrankungen verwendbare kynurensaeurederivate.
NO873125L (no) Fremgangsmaate for fremstilling av antibakterielle forbindelser.
DK0612731T3 (da) Nye quinolon- og naphthyridoncarboxylsyrederivater
DE69020199T2 (de) Durch Azetidine substituierte Derivate von Pyridon-Carboxylsäure, ihre Herstellung und Verwendung als Arzneimittel.
HU9200582D0 (en) Method for producing 2-substituted quinoline and pharmaceutical preparatives containing said compounds
FI900365A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-fenyyli-5,6-dihydrobents/C/akridiini-7-karboksyylihappojohdannnaisten valmistamiseksi
ATE105838T1 (de) 6-fluor-3,5-dihydroxycarbonsäuren und deren derivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische präparate und zwischenprodukte.
GR3020230T3 (en) Acylsulphonamido and sulphonamidopyridine-2-carboxylic acid esters, pyridine-n-oxides thereof, a process for their preparation and their use as medicaments
ATE116282T1 (de) Neue p-oxibenzoesäurederivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE74600T1 (de) Derivate von 5-(2-(1-pyrrolidinyl)-aethoxy>-pcymen, verfahren zu ihrer herstellung und diese derivate enthaltende arzneimittel.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee